24 GIS alerts and GIF notices – weekly safety review

During the period 02.02.2026 - 08.02.2026 the supervisory authorities published 24 alerts concerning the safety of products available on the Polish market. According to notices issued by GIS, GIF and warnings from UOKiK, the most serious issues involved infant formulas with possible contamination by the cereulide toxin, psychiatric and oncology medicines with quality defects, as well as cosmetics containing the banned ingredient BMHCA. There were also warnings about toys, a gas regulator and mineral wool.

The GIS alerts on food and the GIF notices for medicinal products directly affect the health of the most vulnerable groups – infants, children and patients undergoing treatment. The UOKiK warnings and Safety Gate notifications in turn remind us that quality problems can also concern toys, cosmetics or building products. Below we present a weekly summary, a list of recalled food products and other batches under supervision, together with practical advice for consumers.

In brief

• Several GIS alerts concern Bebiko, Bebilon and NAN infant formulas with potential presence of the cereulide toxin (Bacillus cereus), posing a food safety risk for infants.
• GIF notices report withdrawal from the market of specific batches of Lorafen 1 mg and Carmustine Accord 100 mg due to quality non‑compliance.
• UOKiK warnings and Safety Gate notifications cover, among others, a dangerous gas regulator, two toys, three cosmetics with banned BMHCA and mineral wool with lower-than-declared insulation.
• If any of these products has been used, consumers should contact a doctor (for infant food and medicines) or immediately stop using the product and return it to the retailer.

Wycofania z obrotu

Komunikaty i wstrzymania

Wyróżnione komunikaty

BEBIKO 1 nutriFLOR EXPERT 350 g

Hazard: Potential presence of cereulide, a substance produced by the bacterium Bacillus cereus, in specific batches of infant formula may pose a food safety risk. Potential effects: food poisoning, vomiting, diarrhoea, infant malaise.

Store: no data | EAN: 5900852000409 | Manufacturer: NUTRICIA Polska Sp. z o.o.

NAN Optipro Plus 1; 800 g

Hazard: Potential presence of cereulide, a toxic substance produced by the microorganism Bacillus cereus in one of the raw materials (arachidonic oil) used to manufacture the infant formula batches. Potential effects: food poisoning in infants.

Store: no data | EAN: no data | Manufacturer: Nestlé Polska S.A.

Toy balance bike

Hazard: The saddle stem has sharp edges that may cause cuts. Handlebar parts and small components can detach, creating a risk of falling, choking, and suffocation from the thin plastic bag. Potential effects: cuts, injuries from falling, choking, suffocation.

Store: no data | EAN: 5903631473203 | Manufacturer: no data

Palmolive Naturals shower cream 250 ml

Hazard: According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, the health of the unborn child and may cause skin sensitisation. Potential effects: reproductive toxicity, fetal complications, skin allergic reactions.

Store: no data | EAN: 8714789939780 | Manufacturer: PALMOLIVE NATURALS

Analiza zagrożeń zdrowotnych

The Bebiko, Bebilon and NAN infant formulas were covered by GIS alerts due to potential presence of cereulide, a toxin produced by Bacillus cereus. This toxin is heat stable, so preparing the formula with hot water does not eliminate the risk. In infants it can cause sudden vomiting, diarrhoea, dehydration and general weakness, which in this age group may require urgent medical attention. This makes these cases particularly important from a food safety perspective.

Cosmetic products containing BMHCA (formerly known as the fragrance ingredient lilial) violate Regulation (EC) No 1223/2009, which bans substances suspected of reproductive toxicity. BMHCA may impair fertility, increase the risk of fetal damage and trigger skin allergies, which is why it is not allowed in any cosmetics on the EU market. GIS and EU authorities stress that long-term exposure to such compounds may accumulate health risks over time.

Toys with excessive DEHP and DBP phthalates are dangerous because these substances act as endocrine disruptors. According to UOKiK, children exposed to such plasticisers may face long-term reproductive system damage and developmental disorders. Additional mechanical risks – sharp edges, detachable small parts and thin plastic bags – increase the likelihood of injuries, choking and suffocation.

For medicinal products, the GIF notices identify two critical quality defects. In Lorafen 1 mg, non-compliant release of the active substance may lead to lack of therapeutic effect or even worsening of symptoms. In the oncology medicine Carmustine Accord 100 mg, the solvent is contaminated with non-volatile residue from silicone tubing used during manufacturing, meaning the patient receives an infusion of unknown safety profile. GIF underlines that infusion products require the highest purity, and any deviation entails a risk of unpredictable adverse reactions.

Technical hazards must not be underestimated either. A gas regulator that fails to reduce pressure to the required level can lead to uncontrolled gas flow, flare-ups and fire. In the context of everyday use of heating appliances and cooking equipment, this represents a real risk of severe burns and property damage.

Sklepy i instytucje objęte komunikatami

In this week, GIS alerts focus on infant nutrition products from Nutricia (Bebiko, Bebilon) and Nestlé (NAN), which reach consumers mainly through retail chains, pharmacies and online shops. Although the notices do not name specific retailers, consumers should assume that affected batches may have been widely available.

GIF notices concern two medicinal products distributed through pharmacies and hospitals: Lorafen 1 mg (Tarchomińskie Zakłady Farmaceutyczne 'Polfa' S.A.) and Carmustine Accord 100 mg (Accord Healthcare Polska). In practice this means that healthcare facilities and pharmacies must review their stocks, while patients should not change their treatment on their own but consult their doctor.

UOKiK warnings and Safety Gate notifications cover products sold in general consumer channels – from toys and cosmetics to gas installation components and mineral wool. According to UOKiK, retailers are obliged to remove non-compliant batches from shelves, but many items may already be in consumers’ homes. In such cases, users should follow the guidance of the manufacturer and authorities and request replacement or refund where appropriate.

Porady dla konsumentów

Caregivers using the affected infant formulas should first check the product name, batch number and best-before date on the packaging. If these match the GIS notice, the product must be removed from the child’s diet immediately. If symptoms of food poisoning occur – vomiting, diarrhoea, fever or lethargy – prompt contact with a paediatrician or emergency medical service is essential. It is also advisable to monitor further GIS alerts on food safety.

Patients taking Lorafen or treated with Carmustine Accord should not stop therapy on their own. In line with GIF notices, they should contact their prescribing physician or pharmacist, who will verify the batch numbers and decide on possible changes in treatment. Packs from the affected batches should be returned to the pharmacy, which will handle them under the official quality-defect procedure.

For cosmetics containing BMHCA, as well as unsafe toys and the gas regulator, immediate discontinuation of use is recommended. Consumers are entitled to return defective goods at the point of sale – often even without a paper receipt, if they can prove the purchase in another way (bank statement, loyalty card, witness). Food products and other items subject to UOKiK warnings should not simply be thrown into mixed waste if there is any chance they might be reused; returning them via the retailer or as instructed by the manufacturer is safer.

In case of doubt, it is worth using the helplines of GIS, UOKiK or GIF and regularly checking publicly available alerts and notices. Rapid response to such information significantly reduces health risks for household members.

Kontekst prawny

The product safety system in Poland rests on several pillars. In the field of food safety, the Chief Sanitary Inspectorate (GIS) plays the key role, operating under national law and EU rules, including Regulation (EC) No 178/2002. GIS may order the removal from the market of specific food batches when there is a suspicion that they may pose a risk to health.

For medicines, the Chief Pharmaceutical Inspectorate (GIF) is responsible. GIF notices may involve market withdrawal, suspension of distribution or a ban on placing the product on the market. In this week, decisions relating to Lorafen 1 mg and Carmustine Accord 100 mg include both withdrawal of the affected batches and a ban on further marketing, but in this article they are presented separately from the recall table as specific quality communications.

Responsibility for the safety of toys, cosmetics and other consumer products lies, among others, with UOKiK, which cooperates with the EU Safety Gate system (formerly RAPEX). UOKiK warnings and Safety Gate notifications are designed to quickly inform the public about products that pose risks to health or safety. Consumers are entitled to return defective goods, seek compensation in case of damage and access full information about identified hazards.